Cargando…
Immunotherapy of acute myeloid leukemia based on γδ T cells
A current major challenge of acute myeloid leukemia research is to develop immunotherapeutic strategies that would be employable in all patients. We recently reported that appropriately stimulated γδ T cells are fully capable of mediating cytotoxicity against leukemic blasts.
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Landes Bioscience
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525621/ https://www.ncbi.nlm.nih.gov/pubmed/23264912 http://dx.doi.org/10.4161/onci.21512 |
| _version_ | 1782253449623109632 |
|---|---|
| author | Gertner-Dardenne, Julie Fauriat, Cyril Vey, Norbert Olive, Daniel |
| author_facet | Gertner-Dardenne, Julie Fauriat, Cyril Vey, Norbert Olive, Daniel |
| author_sort | Gertner-Dardenne, Julie |
| collection | PubMed |
| description | A current major challenge of acute myeloid leukemia research is to develop immunotherapeutic strategies that would be employable in all patients. We recently reported that appropriately stimulated γδ T cells are fully capable of mediating cytotoxicity against leukemic blasts. |
| format | Online Article Text |
| id | pubmed-3525621 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | Landes Bioscience |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-35256212012-12-21 Immunotherapy of acute myeloid leukemia based on γδ T cells Gertner-Dardenne, Julie Fauriat, Cyril Vey, Norbert Olive, Daniel Oncoimmunology Author's View A current major challenge of acute myeloid leukemia research is to develop immunotherapeutic strategies that would be employable in all patients. We recently reported that appropriately stimulated γδ T cells are fully capable of mediating cytotoxicity against leukemic blasts. Landes Bioscience 2012-12-01 /pmc/articles/PMC3525621/ /pubmed/23264912 http://dx.doi.org/10.4161/onci.21512 Text en Copyright © 2012 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
| spellingShingle | Author's View Gertner-Dardenne, Julie Fauriat, Cyril Vey, Norbert Olive, Daniel Immunotherapy of acute myeloid leukemia based on γδ T cells |
| title | Immunotherapy of acute myeloid leukemia based on γδ T cells |
| title_full | Immunotherapy of acute myeloid leukemia based on γδ T cells |
| title_fullStr | Immunotherapy of acute myeloid leukemia based on γδ T cells |
| title_full_unstemmed | Immunotherapy of acute myeloid leukemia based on γδ T cells |
| title_short | Immunotherapy of acute myeloid leukemia based on γδ T cells |
| title_sort | immunotherapy of acute myeloid leukemia based on γδ t cells |
| topic | Author's View |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525621/ https://www.ncbi.nlm.nih.gov/pubmed/23264912 http://dx.doi.org/10.4161/onci.21512 |
| work_keys_str_mv | AT gertnerdardennejulie immunotherapyofacutemyeloidleukemiabasedongdtcells AT fauriatcyril immunotherapyofacutemyeloidleukemiabasedongdtcells AT veynorbert immunotherapyofacutemyeloidleukemiabasedongdtcells AT olivedaniel immunotherapyofacutemyeloidleukemiabasedongdtcells |